●Prion disease: bridging the spleen–nerve gap. Mabbott, N. A. & Bruce, M. E. Nature Medicine December (2003)

●Unlocking the money- making potential of RNAi. Howard, K. Nature Biotechnology December (2003)

●Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Bowden, G. T. Nature Reviews Cancer January (2004)

●Peroxisome-proliferator-activated receptors and cancers: complex stories. Michalik, L., Desvergne, B. & Wahli, W. Nature Reviews Cancer January (2004)

●The role of sexually transmitted diseases in HIV transmission. Galvin, S. R. & Cohen, M. S. Nature Reviews Microbiology January (2004)

●Can better prescribing turn the tide of resistance? Livermore, D. Nature Reviews Microbiology January (2004)

●Prevention of cervical cancer through papillomavirus vaccination. Frazer, I. H. Nature Reviews Immunology January (2004)

●Dendritic cells: emerging pharmacological targets of immuno- suppressive drugs. Hackstein, H. & Thomson, A. W. Nature Reviews Immunology January (2004)

●Cytokines in cancer pathogenesis and cancer therapy. Dranoff, G. Nature Reviews Cancer January (2004)

●Immunity to fungal infections. Romani, L. Nature Reviews Immunology January (2004)

●The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Laviolette, S. R. & van der Kooy, D. Nature Reviews Neuroscience January (2004)

●Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm. Moatti, J. P. et al. Nature Medicine December (2003)

●Anti-steroid takes aim at neuropathy. De Jonghe, P. & Timmerman, V. Nature Medicine December (2003)